Neoplasms, Colorectal Terminated Phase 2 Trials for Capecitabine (DB01101)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02842580De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal CancerTreatment
NCT02780700Nintedanib Alone or in Combination With Capecitabine in Refractory Metastatic Colorectal Cancer [LUME-Colon 2]Treatment
NCT00314353Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the ColonTreatment
NCT00321100Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without BevacizumabTreatment
NCT00506168Study of Irinotecan & Capecitabine in Metastatic Colorectal CancerTreatment
NCT00950820Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal CancerTreatment